131 related articles for article (PubMed ID: 30022699)
1. Inhibitor selectivity of CNTs and ENTs.
Vaskó B; Juhász V; Tóth B; Kurunczi A; Fekete Z; Krisjanis Zolnerciks J; Kis E; Magnan R; Bidon-Chanal Badia A; Pastor-Anglada M; Hazai E; Bikadi Z; Fülöp F; Krajcsi P
Xenobiotica; 2019 Jul; 49(7):840-851. PubMed ID: 30022699
[TBL] [Abstract][Full Text] [Related]
2. Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine.
Zeng Q; Bai M; Li C; Lu S; Ma Z; Zhao Y; Zhou H; Jiang H; Sun D; Zheng C
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160284
[TBL] [Abstract][Full Text] [Related]
3. Equilibrative Nucleoside Transporter 1 (ENT1,
Cerveny L; Ptackova Z; Ceckova M; Karahoda R; Karbanova S; Jiraskova L; Greenwood SL; Glazier JD; Staud F
Drug Metab Dispos; 2018 Nov; 46(11):1817-1826. PubMed ID: 30097436
[TBL] [Abstract][Full Text] [Related]
4. Functional expression of equilibrative and concentrative nucleoside transporters in alveolar epithelial cells.
Baba S; Yumoto R; Kawami M; Takano M
Pharmazie; 2021 Sep; 76(9):416-421. PubMed ID: 34481531
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
[TBL] [Abstract][Full Text] [Related]
6. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F
Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525
[TBL] [Abstract][Full Text] [Related]
7. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Interaction of Tetrahydrouridine with Key Human Nucleoside Transporters.
Säll C; Koncsos G; Klukovits A
J Pharm Sci; 2023 Oct; 112(10):2676-2684. PubMed ID: 37364771
[TBL] [Abstract][Full Text] [Related]
9. The SLC28 (CNT) and SLC29 (ENT) nucleoside transporter families: a 30-year collaborative odyssey.
Young JD
Biochem Soc Trans; 2016 Jun; 44(3):869-76. PubMed ID: 27284054
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice.
Lu H; Chen C; Klaassen C
Drug Metab Dispos; 2004 Dec; 32(12):1455-61. PubMed ID: 15371301
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside transporters are widely expressed in ovarian carcinoma effusions.
Bock AJ; Dong HP; Tropé CG; Staff AC; Risberg B; Davidson B
Cancer Chemother Pharmacol; 2012 Feb; 69(2):467-75. PubMed ID: 21822668
[TBL] [Abstract][Full Text] [Related]
12. The concentrative nucleoside transporter family, SLC28.
Gray JH; Owen RP; Giacomini KM
Pflugers Arch; 2004 Feb; 447(5):728-34. PubMed ID: 12856181
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
[TBL] [Abstract][Full Text] [Related]
14. Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine.
Takahashi K; Yoshisue K; Chiba M; Nakanishi T; Tamai I
Biopharm Drug Dispos; 2018 Jan; 39(1):38-46. PubMed ID: 29055025
[TBL] [Abstract][Full Text] [Related]
15. Correlation of nucleoside and nucleobase transporter gene expression with antimetabolite drug cytotoxicity.
Lu X; Gong S; Monks A; Zaharevitz D; Moscow JA
J Exp Ther Oncol; 2002; 2(4):200-12. PubMed ID: 12416024
[TBL] [Abstract][Full Text] [Related]
16. Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1.
Miller SR; Lane TR; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Drug Metab Dispos; 2021 Jul; 49(7):479-489. PubMed ID: 33980604
[TBL] [Abstract][Full Text] [Related]
17. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.
Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974
[TBL] [Abstract][Full Text] [Related]
18. Expression of concentrative nucleoside transporters SLC28 (CNT1, CNT2, and CNT3) along the rat nephron: effect of diabetes.
Rodríguez-Mulero S; Errasti-Murugarren E; Ballarín J; Felipe A; Doucet A; Casado FJ; Pastor-Anglada M
Kidney Int; 2005 Aug; 68(2):665-72. PubMed ID: 16014043
[TBL] [Abstract][Full Text] [Related]
19. Transport of ribavirin across the rat and human placental barrier: Roles of nucleoside and ATP-binding cassette drug efflux transporters.
Karbanova S; Cerveny L; Jiraskova L; Karahoda R; Ceckova M; Ptackova Z; Staud F
Biochem Pharmacol; 2019 May; 163():60-70. PubMed ID: 30716294
[TBL] [Abstract][Full Text] [Related]
20. Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells.
Kropotov A; Kulikova V; Nerinovski K; Yakimov A; Svetlova M; Solovjeva L; Sudnitsyna J; Migaud ME; Khodorkovskiy M; Ziegler M; Nikiforov A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
